Pharmaceutical Combinations and Uses Thereof

JP2026501084APending Publication Date: 2026-01-14UNIVERSITY OF MELBOURNE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2025530671
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-11-28
Filing Date
2023-11-28
Publication Date
2026-01-14

Smart Images

  • Figure 2026501084000022
    Figure 2026501084000022
  • Figure 2026501084000023
    Figure 2026501084000023
  • Figure 2026501084000024
    Figure 2026501084000024
Patent Text Reader

Abstract

The present invention relates to pharmaceutical combinations for treating or preventing insulin resistance and related disorders, in particular the use of combinations comprising a 4-epimerase inhibitor and a GLP-1 receptor agonist for treating or preventing insulin resistance and related disorders, suppressing appetite, and / or promoting weight loss, such as obesity and type 2 diabetes.
Need to check novelty before this filing date? Find Prior Art